Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues [Abstract]
Revenue	$ 8,819,786		$ 8,819,786
Type of Revenue [Extensible List]	us-gaap:ProductMember		us-gaap:ProductMember
Operating expenses:
Cost of product sales (excluding amortization and depreciation)	$ 982,836		$ 982,836
Type of Cost Good or Service [Extensible List]	us-gaap:ProductMember		us-gaap:ProductMember
Research and development	$ 15,792,202	$ 14,503,326	$ 28,377,343	$ 31,099,014
Selling, general and administrative	31,160,140	16,344,361	56,863,871	27,592,734
Change in fair value of contingent consideration	(860,000)		(860,000)
Intangible asset amortization	925,650		925,650
Total operating expenses	48,000,828	30,847,687	86,289,700	58,691,748
Loss from operations	(39,181,042)	(30,847,687)	(77,469,914)	(58,691,748)
Interest income (expense)	(2,257,474)	(1,436,522)	(3,600,913)	(2,852,431)
Net loss	$ (41,438,516)	$ (32,284,209)	$ (81,070,827)	$ (61,544,179)
Net loss per common share, basic	$ (1.06)	$ (0.86)	$ (2.09)	$ (1.64)
Net loss per common share, diluted	$ (1.06)	$ (0.86)	$ (2.09)	$ (1.64)
Weighted average common shares outstanding, basic	39,081,100	37,595,069	38,704,227	37,512,716
Weighted average common shares outstanding, diluted	39,081,100	37,595,069	38,704,227	37,512,716